# Presenting Risk Information in Prescription Drug and Medical Device Promotion - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/presenting-risk-information-in-prescription-drug-and-medical-device-promotion/85abd709-63d2-4514-8e97-a628a63a8b2e

> FDA guidance document: Presenting Risk Information in Prescription Drug and Medical Device Promotion. Issue date: May 27, 2009. Get complete insights and analysis.

---

## Details

- Title: Presenting Risk Information in Prescription Drug and Medical Device Promotion
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2009-05-27
- Last Changed: 2019-02-09
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2008-D-0253">FDA-2008-D-0253</a>

## Related Documents

- [Malaria: Developing Drugs for Treatment: Draft Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/malaria-developing-drugs-for-treatment-draft-guidance-for-industry/3edfcacf-7736-421e-9b04-b883ec5cc173)
- [Certification Process of Designated Medical Gases](https://www.globalkeysolutions.net/guidances/guidance-document/certification-process-of-designated-medical-gases/352e5870-5e87-45f6-8ca5-cd7027d3ac49)
- [Pharmacogenomic Data Submissions — Companion Guidance](https://www.globalkeysolutions.net/guidances/guidance-document/pharmacogenomic-data-submissions-companion-guidance/26f5c4db-2ae3-46b8-ae62-dbb909250a16)